Actively Recruiting
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
Led by University of Ulm · Updated on 2026-02-13
60
Participants Needed
1
Research Sites
277 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial to clarify the impact of changes in thyroid hormone levels on glucose and lipid metabolism. Patients will be included in whom thyroid hormone levels are intentionally changed by treatment. In patients with Graves' disease, thyroid hormone levels will be lowered using medication, while in patients with thyroid cancer, thyroid hormone levels will be raised using medication. Oral glucose tolerance tests will be performed before treatment and at two time points after treatment begins to assess metabolic effects.
CONDITIONS
Official Title
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with an initial diagnosis of Graves' disease
- Patients with an initial diagnosis of thyroid carcinoma
You will not qualify if you...
- Contraindications for oral glucose tolerance test
- Diabetes mellitus
- Fasting glucose level 63; 200 mg/dL
- Exogenous insulin administration with action at the time of the test
- Current disease with activation of stress hormones
- Post-aggressive metabolism
- Acute infectious disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ulm University Hospital
Ulm, Baden-Wurttemberg, Germany, 89081
Actively Recruiting
Research Team
M
Martin Heni, Prof
CONTACT
R
Roza Sabia, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here